Human immunity and the design of multi-component, single target vaccines.
about
Phase 1 trial of malaria transmission blocking vaccine candidates Pfs25 and Pvs25 formulated with montanide ISA 51.Sequence conservation in Plasmodium falciparum alpha-helical coiled coil domains proposed for vaccine development.Population biology of malaria within the mosquito: density-dependent processes and potential implications for transmission-blocking interventions.Applying mathematical tools to accelerate vaccine development: modeling Shigella immune dynamicsSterile protective immunity to malaria is associated with a panel of novel P. falciparum antigens.Analysis of a Multi-component Multi-stage Malaria Vaccine Candidate--Tackling the Cocktail ChallengeEnhancing blockade of Plasmodium falciparum erythrocyte invasion: assessing combinations of antibodies against PfRH5 and other merozoite antigens.Malaria vaccines and their potential role in the elimination of malaria.Synergism from combinations of infection-blocking malaria vaccinesEfficacy model for mosquito stage transmission blocking vaccines for malaria.Bliss and Loewe interaction analyses of clinically relevant drug combinations in human colon cancer cell lines reveal complex patterns of synergy and antagonism.A clinically parameterized mathematical model of Shigella immunity to inform vaccine design.Assessment of Antibodies Induced by Multivalent Transmission-Blocking Malaria Vaccines.Efficacy model for antibody-mediated pre-erythrocytic malaria vaccines.
P2860
Q33350210-7A251E52-BAA9-4AE4-A3F6-1649AF7230AAQ33459259-33309A95-929C-47F2-BFCE-520D0EFD37FBQ34332247-155EDDA0-D05A-474D-AA00-F91F7D15FB9EQ34669980-07BA5545-2040-4789-A86E-3613C01C7D21Q35264640-21B7A2A3-D073-45EF-8101-A40389D7FC67Q35683366-9EC59635-B602-48C3-83B8-F56A057D2FA0Q36384456-86D76F0A-D2F9-4A04-9031-177F20861623Q37018637-B3DCE1E0-C6CF-41BE-B541-819FDF0AA2F9Q37151822-8B8F6F12-A7F8-497B-83B3-1BA57835B888Q44140071-D3585CC8-EB90-4FF9-8B95-9E086B9571EDQ47115739-8B996EE6-0BDA-4BA3-9B6A-4331429E10D3Q47205506-D2932460-F1C4-4524-AEB3-82076C6CCC01Q49730085-DB0DC6A6-7658-4808-BCE1-2F3EBEC91D81Q51648048-A5D37E60-DF75-447E-91AF-0F400108DF7F
P2860
Human immunity and the design of multi-component, single target vaccines.
description
2007 nî lūn-bûn
@nan
2007 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Human immunity and the design of multi-component, single target vaccines.
@ast
Human immunity and the design of multi-component, single target vaccines.
@en
Human immunity and the design of multi-component, single target vaccines.
@nl
type
label
Human immunity and the design of multi-component, single target vaccines.
@ast
Human immunity and the design of multi-component, single target vaccines.
@en
Human immunity and the design of multi-component, single target vaccines.
@nl
prefLabel
Human immunity and the design of multi-component, single target vaccines.
@ast
Human immunity and the design of multi-component, single target vaccines.
@en
Human immunity and the design of multi-component, single target vaccines.
@nl
P2860
P1433
P1476
Human immunity and the design of multi-component, single target vaccines.
@en
P2860
P356
10.1371/JOURNAL.PONE.0000850
P407
P577
2007-09-05T00:00:00Z